<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2014-17-96-103</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-782</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НЕВРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NEUROLOGY</subject></subj-group></article-categories><title-group><article-title>Лечение боли у пациентов с остеоартрозом различной локализации</article-title><trans-title-group xml:lang="en"><trans-title>Treatment of pain in patients with osteoarthritis of different location</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чичасова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chichasova</surname><given-names>N. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова<country>Россия</country></aff><aff xml:lang="en">the Sechenov First Moscow State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2014</year></pub-date><volume>0</volume><issue>17</issue><fpage>96</fpage><lpage>103</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чичасова Н.В., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Чичасова Н.В.</copyright-holder><copyright-holder xml:lang="en">Chichasova N.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/782">https://www.med-sovet.pro/jour/article/view/782</self-uri><abstract><p>В настоящее время применение препаратов, способных модифицировать обменные процессы в хряще, привлекает все большее внимание, прежде всего благодаря их высокому профилю безопасности. В статье приводятся данные по применению комбинированных препаратов Терафлекс и Терафлекс Адванс в лечении больных с дегенеративно-дистрофическими заболеваниями суставов и позвоночника.</p></abstract><trans-abstract xml:lang="en"><p>Currently, the use of drugs which can modify metabolic processes in the cartilage attracts increasing attention, primarily because of their high safety profile. The article presents data on the use of combined drugs Theraflex and Theraflex Advance in the treatment of patients with degenerative-dystrophic diseases of the joints and spine.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>остеоартроз</kwd><kwd>модифицирующие средства замедленного действия</kwd><kwd>глюкозамин</kwd><kwd>хондроитина сульфат</kwd><kwd>ибупрофен</kwd><kwd>osteoarthritis</kwd><kwd>delayed-action modifying agents</kwd><kwd>glucosamine</kwd><kwd>chondroitin sulfate</kwd><kwd>ibuprofen</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Smith MM, Ghosh P. Osteoarthritis: Current status and future directions.APLARJRheum, 1998, 2: 27-53.</mixed-citation><mixed-citation xml:lang="en">Smith MM, Ghosh P. Osteoarthritis: Current status and future directions.APLARJRheum, 1998, 2: 27-53.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lawrence RC, Brummer JM, Bier F. Osteoarthritis prevalence in the population and relationship between symptoms and x-ray changes. Ann Rheum Dis, 1966, 25: 1-24.</mixed-citation><mixed-citation xml:lang="en">Lawrence RC, Brummer JM, Bier F. Osteoarthritis prevalence in the population and relationship between symptoms and x-ray changes. Ann Rheum Dis, 1966, 25: 1-24.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lawrence R.C, Helmick CG, Arnett FC. et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum, 1998, 41: 778-799.</mixed-citation><mixed-citation xml:lang="en">Lawrence R.C, Helmick CG, Arnett FC. et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum, 1998, 41: 778-799.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Л.И. Беневоленская, М.М. Бржезовский. Эпидемиология ревматических болезней. М.: Медицина, 1988.</mixed-citation><mixed-citation xml:lang="en">Л.И. Беневоленская, М.М. Бржезовский. Эпидемиология ревматических болезней. М.: Медицина, 1988.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Галушко Е.А., Большакова Т.В., Виноградова И.Б. и др. Структура ревматических заболеваний среди взрослого населения России по данным эпидемиологического исследования (предварительные результаты). Научно-практ. Ревматология, 2009, 1: 11-17.</mixed-citation><mixed-citation xml:lang="en">Галушко Е.А., Большакова Т.В., Виноградова И.Б. и др. Структура ревматических заболеваний среди взрослого населения России по данным эпидемиологического исследования (предварительные результаты). Научно-практ. Ревматология, 2009, 1: 11-17.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jordan KM, Arden NK, Doherty M. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2003, 62: 1145-1155.</mixed-citation><mixed-citation xml:lang="en">Jordan KM, Arden NK, Doherty M. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2003, 62: 1145-1155.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Верткин А.Л., Алексеева Л.И., Наумов А.В. и др. Остеоартроз в практике врача-терапевта. РМЖ, 2008, 16(7): 33-37.</mixed-citation><mixed-citation xml:lang="en">Верткин А.Л., Алексеева Л.И., Наумов А.В. и др. Остеоартроз в практике врача-терапевта. РМЖ, 2008, 16(7): 33-37.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">van Dijk GV, Veenhof C, Schelleviset S, et. al. Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet. Disord, 2008, 9: 95.</mixed-citation><mixed-citation xml:lang="en">van Dijk GV, Veenhof C, Schelleviset S, et. al. Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet. Disord, 2008, 9: 95.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов Е.Л., Лазебник Л.Б., Беленков Ю.Н. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М., 2006.</mixed-citation><mixed-citation xml:lang="en">Насонов Е.Л., Лазебник Л.Б., Беленков Ю.Н. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М., 2006.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Blot L, Marcelis A, Devogelaer JP, Manicourt DH. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human articular cartilage. BrJPharmacol, 2000, 131: 1413-1421.</mixed-citation><mixed-citation xml:lang="en">Blot L, Marcelis A, Devogelaer JP, Manicourt DH. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human articular cartilage. BrJPharmacol, 2000, 131: 1413-1421.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Delafuente JC. Glucosamine in the treatment of osteoarthritis. Rheum Dis Clin North Am, 2000, 26: 1-11.</mixed-citation><mixed-citation xml:lang="en">Delafuente JC. Glucosamine in the treatment of osteoarthritis. Rheum Dis Clin North Am, 2000, 26: 1-11.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Houpt JB, McMillan R. et al. Effect of treatment of glucosamine hydrochloride in the treatment of pain in osteoarthritis of the knee. J Rheum, 1998, 25 (suppl. 52): 8.</mixed-citation><mixed-citation xml:lang="en">Houpt JB, McMillan R. et al. Effect of treatment of glucosamine hydrochloride in the treatment of pain in osteoarthritis of the knee. J Rheum, 1998, 25 (suppl. 52): 8.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mazieres B, Combe B, Phan Van V, et.al. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. J Rheum, 2001, 28: 173-181.</mixed-citation><mixed-citation xml:lang="en">Mazieres B, Combe B, Phan Van V, et.al. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. J Rheum, 2001, 28: 173-181.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">McAlindon TE, LaValley MP, Gulin JP, Felson DT Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and metaanalysis. JAMA, 2000, 283: 1469-1475.</mixed-citation><mixed-citation xml:lang="en">McAlindon TE, LaValley MP, Gulin JP, Felson DT Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and metaanalysis. JAMA, 2000, 283: 1469-1475.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Leeb BF, Schweitzer H, Montag K, Smolen JS. A meta-analysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol, 2000, 27: 205-211.</mixed-citation><mixed-citation xml:lang="en">Leeb BF, Schweitzer H, Montag K, Smolen JS. A meta-analysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol, 2000, 27: 205-211.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
